Unboxing herpes zoster ophthalmicus and the recombinant shingles vaccine
Medicine Today
; 22(11):33-39, 2021.
Article
in English
| Scopus | ID: covidwho-2011995
ABSTRACT
Reactivation of the varicella zoster virus as herpes zoster (shingles) typically affects the peripheral nerves, resulting in a painful rash, most often on the torso. However, it can also manifest ophthalmologically, affecting the ophthalmic division of the trigeminal nerve. This manifestation is associated with a particularly high level of morbidity and may result in blindness. A new recombinant shingles herpes zoster vaccine protects patients against this virus and post-infection sequelae, improving medical and psychosocial outcomes. © 2021 Medicine Today Pty Ltd. All rights reserved.
capsaicin; corticosteroid; gabapentin; lidocaine; pregabalin; SARS-CoV-2 vaccine; varicella zoster vaccine; antiviral therapy; Article; coronavirus disease 2019; herpes zoster; herpes zoster ophthalmicus; human; keratitis; keratoconjunctivitis; postherpetic neuralgia; practice guideline; trigeminal nerve; uveitis
Search on Google
Collection:
Databases of international organizations
Database:
Scopus
Topics:
Vaccines
Language:
English
Journal:
Medicine Today
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS